XDH and hydrops fetalis: Another XOR inhibitor, allopurinol, failed to improve clinical status in patients with HF with reduced ejection fraction (≤40%) and elevated serum uric acid levels (≥9.5 mg/dL) in the EXACT-HF (the Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients) trial [136].